Konstantinos Anagnostakos1, Luise Duchow2, Katrin Koch2. 1. Klinik für Orthopädie und Orthopädische Chirurgie, Universitätsklinikum des Saarlandes, Kirrbergerstr. 100, 66421, Homburg, Saar, Germany. k.anagnostakos@web.de. 2. Klinik für Orthopädie und Orthopädische Chirurgie, Universitätsklinikum des Saarlandes, Kirrbergerstr. 100, 66421, Homburg, Saar, Germany.
Abstract
INTRODUCTION: The ideal treatment of the destructive septic arthritis of the hip joint remains controversial. The aim of the present retrospective study was to report on our experience about the use of antibiotic-loaded cement spacers in the treatment of destructive bacterial coxitis. MATERIALS AND METHODS: 22 consecutive patients (11 male, 11 female, mean age 59.7 years) have been treated with a two-stage protocol and implantation of an antibiotic-loaded cement spacer. All patients' records have been retrospectively evaluated with regard to comorbidities/predisposing factors, infection cause, causative pathogen organism, presence of a psoas abscess, surgical time of spacer implantation, duration of spacer implantation, spacer articulation, impregnation of bone cement, systemic antibiotic therapy, surgical time of prosthesis implantation, implant type, complications, and infection control rate. RESULTS: The most common identified organism was Staphylococcus aureus (73 %). The mean duration of spacer implantation was 88 days. Spacer-specific complications were observed in 23 % of the cases and spacer non-specific ones in 50 % between stages. The mortality rate after the first stage was 18 %. Prosthesis implantation was performed in 16 cases. At a mean follow-up of 44.8 (12-120) months, the primary infection control rate (after one spacer implantation) was 87 % (13/15) and the secondary infection control rate (after two spacer implantations) 100 %. CONCLUSIONS: Two-stage treatment and spacer implantation is associated with a high rate of infection control but also with a high mortality rate between stages.
INTRODUCTION: The ideal treatment of the destructive septic arthritis of the hip joint remains controversial. The aim of the present retrospective study was to report on our experience about the use of antibiotic-loaded cement spacers in the treatment of destructive bacterial coxitis. MATERIALS AND METHODS: 22 consecutive patients (11 male, 11 female, mean age 59.7 years) have been treated with a two-stage protocol and implantation of an antibiotic-loaded cement spacer. All patients' records have been retrospectively evaluated with regard to comorbidities/predisposing factors, infection cause, causative pathogen organism, presence of a psoas abscess, surgical time of spacer implantation, duration of spacer implantation, spacer articulation, impregnation of bone cement, systemic antibiotic therapy, surgical time of prosthesis implantation, implant type, complications, and infection control rate. RESULTS: The most common identified organism was Staphylococcus aureus (73 %). The mean duration of spacer implantation was 88 days. Spacer-specific complications were observed in 23 % of the cases and spacer non-specific ones in 50 % between stages. The mortality rate after the first stage was 18 %. Prosthesis implantation was performed in 16 cases. At a mean follow-up of 44.8 (12-120) months, the primary infection control rate (after one spacer implantation) was 87 % (13/15) and the secondary infection control rate (after two spacer implantations) 100 %. CONCLUSIONS: Two-stage treatment and spacer implantation is associated with a high rate of infection control but also with a high mortality rate between stages.
Entities:
Keywords:
Cement spacer; Coxitis; Hip spacer; Mortality; Septic arthritis
Authors: Moneer M Abouljoud; David Backstein; Andrew Battenberg; Matthew Dietz; Alejo Erice; Andrew A Freiberg; Jeffrey Granger; Adam Katchky; Anton Khlopas; Tae-Kyun Kim; Per Kjaersgaard-Andersen; Kyung-Hoi Koo; Yona Kosashvili; Percia Lazarovski; Jennifer Leighton; Adolph Lombardi; Konstantinos Malizos; Jorge Manrique; Michael A Mont; Marianthe Papanagiotoy; Rafael J Sierra; Nipun Sodhi; John Stammers; Maik Stiehler; Timothy L Tan; Katsufumi Uchiyama; Derek Ward; Anna Ziogkou Journal: J Arthroplasty Date: 2018-10-19 Impact factor: 4.757
Authors: Christina Rimke; Andreas Enz; Hermann Josef Bail; Peter Heppt; Bernd Kladny; Gabriela von Lewinski; Christoph H Lohmann; Katrin Osmanski-Zenk; Holger Haas; Wolfram Mittelmeier Journal: BMC Musculoskelet Disord Date: 2020-10-19 Impact factor: 2.362
Authors: Antonio Russo; Luca Cavagnaro; Francesco Chiarlone; Antonio Clemente; Sergio Romagnoli; Giorgio Burastero Journal: Int Orthop Date: 2021-03-27 Impact factor: 3.075